Fig. 2From: Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancerNumber of variants detected in plasma cfDNA. A Number of variants in plasma separated on diagnosis. Controls consisted of patients referred to the lung clinic with the suspicion of lung cancer but later diagnosed with different benign lung diseases. B Number of variants in plasma separated on stage. AC adenocarcinoma, SqCC squamous cell carcinoma, SCLC small cell lung cancerBack to article page